HENOCH SCHÖNLEIN PURPURA NEPHRITIS

Clinical trials for HENOCH SCHÖNLEIN PURPURA NEPHRITIS explained in plain language.

Never miss a new study

Get alerted when new HENOCH SCHÖNLEIN PURPURA NEPHRITIS trials appear

Sign up with your email to follow new studies for HENOCH SCHÖNLEIN PURPURA NEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with kidney disease: finerenone trial launches

Disease control Recruiting now

This study tests finerenone, a drug that may reduce kidney inflammation and protein leakage, in children aged 3–17 with Henoch-Schönlein purpura nephritis and mild proteinuria. About 116 participants will receive finerenone to see if it lowers urine protein better than current st…

Matched conditions: HENOCH SCHÖNLEIN PURPURA NEPHRITIS

Phase: PHASE4 • Sponsor: Capital Institute of Pediatrics, China • Aim: Disease control

Last updated May 05, 2026 11:54 UTC

HENOCH SCHÖNLEIN PURPURA NEPHRITIS

Get alerted when new HENOCH SCHÖNLEIN PURPURA NEPHRITIS trials appear

New hope for kids with kidney disease: finerenone trial launches